Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06871683

ClotTriever® Thrombectomy System Use-Result Survey in Japan

The objective of this survey is to determine the safety and efficacy of the ClotTriever Thrombectomy System under daily clinical practice after marketing approval in Japan.

This device was designated as a subject of use results evaluation at the time of application for manufacturing and marketing approval.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Deep Vein Thrombosis Cardiovascular Diseases Embolism and Thrombosis Thrombosis Vascular Diseases Venous Thrombosis

Sex eligibility

All sexes

Study type

Observational

Primary location

Chiba University Hospital, Chuo, Chiba, Japan

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

This is an all-comers survey of all patients treated with ClotTriever® Thrombectomy System in Japan.

Treatment and study plan

ClotTriever® Thrombectomy System

Device

ClotTriever® Thrombectomy System use for treatment of patients with deep vein thrombosis with acute severe symptoms.

Primary outcomes

  1. Rate of Major Adverse Events

    Time frame: Through 30 days post index procedure.

    Rate of Major Adverse Events [All-cause mortality, Major bleeding, New symptomatic Pulmonary Embolism (PE) documented by Computed Tomography Pulmonary Angiography (CTPA), Rethrombosis of a Target Venous Segment].

  2. Technical Success

    Time frame: During the index procedure

    Thrombus residual volume assessed by the the treating physician using pre- and post-procedure venography to evaluate the success of thrombus removal.

Sponsors and collaborators

Lead sponsor

Inari Medical

Industry

Collaborators

  • Vorpal Technologies

Registry information

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
Mar 12, 2025
Registry last updated
Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.